While literature indicates that FABP4 levels increase in atherosclerotic diseases [19–24], a meta-analysis found that a 1-SD decrease in FABP4 among Type 1 diabetes mellitus patients increased the risk of CAD by 2.4-fold [25]. The gene discussed is FABP4; the disease is type 1 diabetes mellitus.